Allergen has acquired Chase Pharmaceuticals Corporation from New Rhein Healthcare Investors for a purchase consideration of $125m.

Pursuant to the agreement, Chase Pharma will be merged with a subsidiary of Allergan, and Allergan will be responsible to pay additional potential regulatory and sales milestone-based payments to Chase Pharma.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The acquisition will allow the acquirer to further expand its CNS research and development (R&D) pipeline.

"The acquisition will allow the acquirer to further expand its CNS research and development (R&D) pipeline."

Primex Pharmaceuticals has acquired Giovanni Ogna& Figli with the aim of expanding its product portfolio of dental surgery products.

Pursuant to the agreement, Primex will merge all the former OGNA companies into the original company, Giovanni Ogna et Figli.

Chiesi Farmaceutici plans to acquire Atopix Therapeutics by purchasing all its outstanding shares for a purchase consideration of $79.4m.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition will enable Chiesi Framaceutici to expand its product portfolio for respiratory and eosinophilic airways diseases.

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now